Fetal echocardiography at the time of the nuchal translucency scan

Ultrasound in Obstetrics and Gynecology

Volumn 29, Issue 3, 2007, Pages 249-257

  Lombardi, C M ^a   Bellotti, M ^b   Fesslova, V ^c   Cappellini, A ^c  

^a Studio Diagnostico Eco   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c UNIVERSITY OF MILANO BICOCCA   (Italy)

Author keywords

Chromosomal anomalies; Congenital heart disease; Fetal echocardiography; First trimester; Nuchal translucency; Prenatal diagnosis; Trisomy 21

Indexed keywords

ARTICLE; CARDIOVASCULAR DISEASE; CONGENITAL HEART DISEASE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FETUS; FETUS ECHOGRAPHY; FETUS HEART; FIRST TRIMESTER PREGNANCY; FOLLOW UP; HUMAN; HUMAN EXPERIMENT; NUCHAL TRANSLUCENCY MEASUREMENT; PRIORITY JOURNAL; ULTRASOUND;

ADULT; CROWN-RUMP LENGTH; FEASIBILITY STUDIES; FEMALE; FETAL DISEASES; FETAL HEART; HEART DEFECTS, CONGENITAL; HUMANS; MASS SCREENING; NUCHAL TRANSLUCENCY MEASUREMENT; PREGNANCY; PREGNANCY TRIMESTER, FIRST; SENSITIVITY AND SPECIFICITY; TIME FACTORS; ULTRASONOGRAPHY, PRENATAL;

EID: 33947393554     PISSN: 09607692     EISSN: 14690705     Source Type: Journal    
DOI: 10.1002/uog.3948     Document Type: Article

References (47)

1. Gembruch U, Knopfle G, Bald R, Hansmann M. Early diagnosis of fetal congenital heart disease by transvaginal echocardiography. Ultrasound Obstet Gynecol 1993; 3: 310-317.
2. Allan LD, Santos R, Pexieder T. Anatomical and echocardiographic correlates of normal cardiac morphology in the late first trimester fetus. Heart 1997; 77: 68-72.
3. Carvalho JS, Moscoso G, Ville Y. First-trimester transabdominal fetal echocardiography. Lancet 1998; 351: 1023-1027.
4. Smrcek JM, Berg C, Geipel A, Fimmers R, Axt-Fliedner R, Diedrich K, Gembruch U. Early fetal echocardiography: heart biometry and visualization of cardiac structures between and 15 weeks' gestation. J Ultrasound Med 2006; 25: 173-178.
5. Hyett J. Patient choice and the randomized controlled trial. Ultrasound Obstet Gynecology 2005; 25: 535-536.
6. Spencer K, Spencer CE, Power M, Dawson C, Nicolaides KH. Screening for chromosomal abnormalities in the first trimester using ultrasound and maternal serum biochemistry in a one-stop clinic: a review of three years prospective experience. BJOG 2003; 110:281-286.
7. Nicolaides KH, Spencer K, Avgidou K, Faiola S, Falcon O. Multicenter study of first-trimester screening for trisomy 21 in 75 821 pregnancies: results and estimation of the potential impact of individual risk-orientated two-stage first-trimester screening. Ultrasound Obstet Gynecol 2005; 25: 221-226.
8. Cicero S, Rembouskos G, Vandecruys H, Hogg M, Nicolaides KH. Likelihood ratio for trisomy 21 in fetuses with absent nasal bone at the 11 - 14-week scan. Ultrasound Obstet Gynecol 2004; 23: 218-223.
9. Cicero S, Spencer K, Avgidou K, Faiola S, Nicolaides KH. Maternal serum biochemistry at 11-13+ 6 weeks in relation to the presence or absence of the fetal nasal bone on ultrasonography in chromosomally abnormal fetuses: an updated analysis of integrated ultrasound and biochemical screening. Prenat Diagn 2005; 25: 977-983.
10. Huggon IC, DeFigueiredo DB, Allan LD. Tricuspid regurgitation in the diagnosis of chromosomal anomalies in the fetus at 11-14 weeks of gestation. Heart 2003; 89: 1071-1073.
11. Faiola S, Tsoi E, Huggon IC, Allan LD, Nicolaides KH. Likelihood ratio for trisomy 21 in fetuses with tricuspid regurgitation at the 11 to 13 + 6-week scan. Ultrasound Obstet Gynecol 2005; 26: 22-27.
12. Falcon O, Faiola S, Huggon I, Allan L, Nicolaides KH. Fetal tricuspid regurgitation at the 11 + 0 to 13 + 6-week scan: association with chromosomal defects and reproducibility of the method. Ultrasound Obstet Gynecol 2006; 27: 609-612.
13. Falcon O, Auer M, Gerovassili A, Spencer K, Nicolaides KH. Screening for trisomy 21 by fetal tricuspid regurgitation, nuchal translucency and maternal serum free beta-hCG and PAPP-A at 11 + 0 to 13 + 6 weeks. Ultrasound Obstet Gynecol 2006; 27: 151-155.
14. Matias A, Huggon I, Areias JC, Montenegro N, Nicolaides KH. Cardiac defects in chromosomally normal fetuses with abnormal ductus venosus blood flow at 10-14 weeks. Ultrasound Obstet Gynecol 1999; 14: 307-310.
15. Chaoui R, Heling KS, Sarioglu N, Schwabe M, Dankof A, Bollmann R. Aberrant right subclavian artery as a new cardiac sign in second and third-trimester fetuses with Down syndrome. Am J Obstet Gynecol 2005; 192: 257-263.
16. Chaoui R. Prenatal ultrasound diagnosis of Down syndrome. After major malformations, soft markers, nuchal translucency and skeletal signs, a new vascular sign? Ultrasound Obstet Gynecol 2005; 26: 214-217.
17. BergC, Knuppel M, Geipel A, Kohl T, Krapp M, Knopfle G, Germer U, Hansmann M, Gembruch U. Prenatal diagnosis of persistent left superior vena cava and its associated congenital anomalies. Ultrasound Obstet Gynecol 2006; 27: 252-265.
18. Li CM, Guo M, Salas M, Schupf N, Silverman W, Zigman WB, Husain S, Warburton D, Thaker H, Tycko B. Cell type-specific over-expression of chromosome 21 genes in fibroblasts and fetal hearts with trisomy 21. BMC Med Genet 2006; 7: 24.
19. Rustico MA, Benettoni A, D'Ottavio G, Fischer-Tamaro L, Conoscenti GC, Meir Y, Natale R, Bussani R, Mandruzzato GP. Early screening for fetal cardiac anomalies in an unselected population: the role of operator experience. Ultrasound Obstet Gynecol 2000; 16: 614-619.
20. Schwarzler P, Carvalho JS, Senat MV, Masroor T, Campbell S, Ville Y. Screening for fetal aneuploidies and fetal cardiac abnormalities by nuchal translucency thickness measurement at 10-14 weeks of gestation as part of routine antenatal care in an unselected population. Br J Obstet Gynaecol 1999; 106: 1029-1034.
21. Bronshtein M, Zimmer EZ. The sonographic approach to the detection of fetal cardiac anomalies in early pregnancy. Ultrasound Obstet Gynecol 2002; 19: 360-365.
22. Chaoui R, McEwing R. Three cross-sectional planes for fetal color Doppler echocardiography. Ultrasound Obstet Gynecol 2003; 21: 81-93.
23. Carvalho JS. Early prenatal diagnosis of major congenital heart defects. Curr Opin Obstet Gynecol 2001; 13: 155-159.
24. Yagel S, Cohen SM, Achiron R. Examination of the fetal heart by five short-axis views: a proposed screening method for comprehensive cardiac examination. Ultrasound Obstet Gynecol 2001; 17: 367-369.
25. Souka AP, Pilalis A, Kavalakis I, Antsaklis P, Papantoniou N, Mesogitis S, Antsaklis A. Screening for major structural abnormalities at the 11- to 14-week ultrasound scan. Am J Obstet Gynecol 2006; 194: 393-396.
26. Weisz B, Pajkrt E, Jauniaux E. Early detection of fetal structural abnormalities. Reprod Biomed 2005; 10: 541-553.
27. Souka AP, Von Kaisenberg CS, Hyett JA, Sonek JD, Nicolaides KH. Increased nuchal translucency with normal karyotype. Am J Obstet Gynecol 2005; 192: 1005-1021.
28. Cook AC, Yates RW, Anderson RH. Normal and abnormal fetal cardiac anatomy. Prenat Diagn 2004; 24: 1032-1048.
29. Anderson RH, Webb S, Brown NA, Lamers W, Moorman A. Development of the heart: (3) formation of the ventricular outflow tracts, arterial valves and intrapericardial arterial trunks. Heart 2003; 89: 1110-1118.
30. de Lange FJ, Moorman AF, Anderson RH, Manner J, Soufan AT, de Gier-de Vries C, Schneider MD, Webb S, van den Hoff MJ, Christoffels VM. Lineage and morphogenetic analysis of the cardiac valves. Circ Res 2004; 95: 645-654.
31. Game E, Stoll C, Clementi M. Evaluation of prenatal diagnosis of congenital heart diseases by ultrasound: experience from 20 European registries. Ultrasound Obstet Gynecol 2001; 17: 386-391.
32. Game E, Loane M, Dolk H, De Vigan C, Scarano G, Tucker D, Stoll C, Gener B, Pierini A, Nelen V, Rosch C, Gillerot Y, Feijoo M, Tincheva R, Queisser-Luft A, Addor MC, Mosquera C, Gatt M, Barisic I. Prenatal diagnosis of severe structural congenital malformations in Europe. Ultrasound Obstet Gynecol 2005; 25: 6-11.
33. Pajkrt E, Weisz B, Firth HV, Chitty LS. Fetal cardiac anomalies and genetic syndromes. Prenat Diagn 2004; 24: 1104-1115.
34. Hyett JA, Perdu M, Sharland GK, Snijders RS, Nicolaides KH. Increased nuchal translucency at 10-14 weeks of gestation as a marker for major cardiac defects. Ultrasound Obstet Gynecol 1997; 10: 242-246.
35. Ghi T, Huggon IC, Zosmer N, Nicolaides KH. Incidence of major structural cardiac defects associated with increased nuchal translucency but normal karyotype. Ultrasound Obstet Gynecol 2001; 18: 610-614.
36. Maher JE, Colvin EV, Samdarshi TE, Owen J, Hauth JC. Fetal echocardiography in gravidas with historic risk factors for congenital heart disease. Am J Perinatol 1994; 11: 334-336.
37. Mavrides E, Cobian-Sanchez F, Tekay A, Moscoso G, Campbell S, Thilaganathan B, Carvalho JS. Limitations of using first-trimester nuchal translucency measurement in routine screening for major congenital heart defects. Ultrasound Obstet Gynecol 2001; 17: 106-110.
38. Hyett J. Does nuchal translucency have a role in fetal cardiac screening? Prenat Diagn 2004; 24: 1130-1135.
39. AtzeiA, Gajewska K, Huggon IC, Allan L, Nicolaides KH. Relation between nuchal translucency thickness and prevalence of major cardiac defects in fetuses with normal karyotype. Ultrasound Obstet Gynecol 2005; 26: 154-157.
40. Makrydimas G, Sotiriadis A, Huggon IC, Simpson J, Sharland G, Carvalho JS, Daubeney PE, Ioannidis JP. Nuchal translucency and fetal cardiac defects: a pooled analysis of major fetal echocardiography centers. Am J Obstet Gynecol 2005; 192: 89-95.
41. Carvalho JS. Fetal heart scanning in the first trimester. Prenat Diagn 2004; 24: 1060-1067.
42. Carvalho JS, Mavrides E, Shinebourne EA, Campbell S, Thilaganathan B. Improving the effectiveness of routine prenatal screening for major congenital heart defects. Heart 2002; 88: 387-391.
43. McAuliffeF, Hornberger L, Winsor S, Chitayat D, Chong K, Johnson J. Fetal cardiac defects and increased nuchal translucency thickness. Am J Obstet Gynecol 2004; 191: 1486-1490.
44. Weiner Z, Lorber A, Shalev E. Diagnosis of congenital cardiac defects between 11 and 14 weeks' gestation in high-risk patients. J Ultrasound Med 2002; 21: 23-29.
45. Huggon IC, Ghi T, Cook AC, Zosmer N, Allan LD, Nicolaides KH. Fetal cardiac abnormalities identified prior to 14 weeks' gestation. Ultrasound Obstet Gynecol 2002; 20: 22-29.
46. Comas Gabriel C, Galindo A, Martinez JM, Carrera JM, Gutierrez-Larraya F, de la Fuente P, Puerto B, Borrell A. Early prenatal diagnosis of major cardiac anomalies in a high-risk population. Prenat Diagn 2002; 22: 586-593.
47. Campbell S. First-trimester screening for pre-eclampsia. Ultrasound Obstet Gynecol 2005; 26: 487-489.